MARKET

PBH

PBH

Prestige Consmr Healthcare Inc
NYSE
50.32
-0.43
-0.85%
After Hours: 50.32 0 0.00% 16:00 09/23 EDT
OPEN
50.43
PREV CLOSE
50.75
HIGH
50.73
LOW
49.50
VOLUME
360.11K
TURNOVER
0
52 WEEK HIGH
63.83
52 WEEK LOW
49.50
MARKET CAP
2.50B
P/E (TTM)
12.61
1D
5D
1M
3M
1Y
5Y
Declining Stock and Decent Financials: Is The Market Wrong About Prestige Consumer Healthcare Inc. (NYSE:PBH)?
It is hard to get excited after looking at Prestige Consumer Healthcare's (NYSE:PBH) recent performance, when its stock...
Simply Wall St. · 09/18 12:26
Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference
TARRYTOWN, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) will present at the 2022 Barclays Global Consumer Staples Conference on Thursday, September 8, 2022 at 12:45 p.m. ET. All interested parties may access a live ...
GlobeNewswire · 09/07 21:03
Down 12.1% in 4 Weeks, Here's Why Prestige Brands (PBH) Looks Ripe for a Turnaround
Prestige Brands (PBH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks · 08/29 13:35
Prestige Consumer's Return on Invested Capital Overview
According to Benzinga Pro, during Q1, Prestige Consumer (NYSE:PBH) earned $55.27 million, a 6.12% increase from the preceding quarter. Prestige Consumer also posted a total of $277.06 million in sales, a 3.79% increase since Q4.
Benzinga · 08/26 14:34
Prestige Brands (PBH) Moves to Buy: Rationale Behind the Upgrade
Prestige Brands (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 08/23 16:00
Earnings Outlook For Prestige Consumer
Prestige Consumer (NYSE:PBH) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Prestige Consumer will report an earnings per share (EPS) of $1.04....
Benzinga · 08/04 17:56
Prestige Consumer Earlier Reported Q1 EPS $1.09 Beats $1.04 Estimate, Sales $277.06M Beat $268.93M Estimate
Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.09 per share which beat the analyst consensus estimate of $1.04 by 4.81 percent. This is a 4.39 percent decrease over earnings of $1.14 per share from the
Benzinga · 08/04 11:36
Prestige Consumer: Q1 Earnings Insights
  Prestige Consumer (NYSE:PBH) reported its Q1 earnings results on Thursday, August 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Benzinga · 08/04 11:30
More
About PBH
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, TheraTears, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet Company, Incorporated, Care Pharmaceuticals Pty Limited, DenTek Holdings, Inc., Medtech Holdings, Inc., Peaks HBC Company, Inc. and others.

Webull offers kinds of Prestige Consumer Healthcare Inc stock information, including NYSE:PBH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PBH stock methods without spending real money on the virtual paper trading platform.